Abstract | BACKGROUND: We have previously shown that seropositivity to rLinB-13, a salivary protein from Lutzomyia intermedia, predicted sand fly exposure and was associated with increased risk of developing cutaneous leishmaniasis (CL). METHODS: Here, we investigated the cellular immune response to saliva from Lu. intermedia, using rLinB-13 as a surrogate antigen in naturally exposed individuals presenting positive serology to LinB-13. We also investigated the response to rLinB-13 in leishmaniasis patients, displaying active ulcers and positive PCR for Leishmania braziliensis. RESULTS: Peripheral blood mononuclear cells (PBMCs) stimulated in vitro with rLinB-13 secreted elevated levels of interleukin-10 (IL-10), IL-4, IL-1β, IL-1α, IL-6, and chemokines (CCL3, CCL4, CCL5, and CXCL5). CL and disseminated leishmaniasis (DL) patients displayed a significantly higher immunoglobulin G ( IgG) response to rLinB-13 compared with healthy subjects, and anti-rLinB-13 IgG was positively correlated with the number of lesions in DL patients. Positive serology to rLinB-13 was also associated with chemotherapy failure. PBMCs from DL patients stimulated with rLINB-13 secreted significantly higher levels of IL-10 and IL-1β compared with CL individuals. CONCLUSIONS: In this study, we observed an association between humoral and cellular immune response to the sand fly salivary protein rLinB-13 and disease severity in tegumentary leishmaniasis. This study brings evidence that immunity to rLinB-13 influences disease outcome in L. braziliensis infection and results indicate that positive serology to rLinB-13 IgG can be used as a marker of DL, an emerging and severe form of disease caused by L. braziliensis.
|
Authors | Augusto M Carvalho, Sayonara M Viana, Bruno B Andrade, Fabiano Oliveira, Jesus G Valenzuela, Edgar M Carvalho, Camila I de Oliveira |
Journal | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
(Clin Infect Dis)
Vol. 75
Issue 10
Pg. 1754-1762
(11 14 2022)
ISSN: 1537-6591 [Electronic] United States |
PMID | 35385578
(Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, N.I.H., Intramural)
|
Copyright | Published by Oxford University Press for the Infectious Diseases Society of America 2022. |
Chemical References |
- Interleukin-10
- Salivary Proteins and Peptides
- Immunoglobulin G
|
Topics |
- Animals
- Interleukin-10
(metabolism)
- Leukocytes, Mononuclear
- Psychodidae
- Salivary Proteins and Peptides
- Leishmania braziliensis
- Leishmaniasis, Cutaneous
- Phlebotomus
- Immunity, Cellular
- Immunoglobulin G
- Severity of Illness Index
|